Global Sickle Cell Anemia Testing Market to Reach $1.63 Billion by 2034, Driven by Newborn Screening and Molecular Diagnostics

The Sickle Cell Anemia Testing and Screening Market offers growth opportunities through expanded newborn testing, molecular diagnostics, and digital workflows. Companies must innovate and improve usability while managing access disparities and handling local market dynamics. Focus on partnerships, technical progress, and responsive supply chains will be key to success.